Chronic myeloid leukemia (CML) is a hematopoietic malignancy characterized by BCR-ABL1 gene fusion. The immune microenvironment, implicated in relapse and drug resistance, poses significant challenges ...
Acute promyelocytic leukemia (APL) represents a paradigm of targeted therapy in hematologic malignancies. Once regarded as ...